Literature DB >> 12745542

Human intestinal epithelial and smooth muscle cells are potent producers of IL-6.

Edmond K Ng1, Ninder Panesar, Walter E Longo, Marc J Shapiro, Donald L Kaminski, Kym C Tolman, John E Mazuski.   

Abstract

BACKGROUND: Interleukin-6 (IL-6), a pluripotent cytokine, has traditionally been considered the product of proinflammatory cells. However, many other cell types have been shown to produce IL-6. Since intestinal inflammation is commonly associated with a vigorous systemic inflammatory response, we hypothesized that intestinal epithelial and smooth muscle cells might contribute to that response by producing IL-6. We therefore studied the capacity of differentiated human intestinal epithelial and smooth muscle cell lines to produce IL-6 in response to various proinflammatory stimuli.
MATERIALS AND METHODS: CCL-241, a human intestinal epithelial cell line, and HISM, a human intestinal muscle cell line, were grown to confluency and then treated for 24 h with various concentrations of lipopolysaccharide, Clostridium difficile culture extract containing both toxin A and toxin B, recombinant human tumor necrosis factor-alpha (TNF-alpha), or recombinant human interleukin-1 beta (IL-1beta). Supernatants were then collected for IL-6 determination using an enzyme-linked immunosorbent assay. Cell numbers were determined using a Coulter counter. For comparison, parallel studies were performed using phorbol ester-primed U-937 and THP-1 human macrophage cell lines.
RESULTS: Both human intestinal epithelial and smooth muscle cells produced IL-6 under basal conditions. In HISM cells, but not in CCL-241 cells, IL-6 release was increased slightly by treatment with C. difficile culture extract containing both toxin A and toxin B and with lipopolysaccharide. In both cell lines, IL-6 production was profoundly stimulated by treatment with IL-1beta and less so with TNF-alpha. Combinations of high-dose TNF-alpha and IL-1beta may have a slightly additive, but not synergistic, effect on IL-6 release. The amount of IL-6 produced by IL-1-stimulated intestinal cell lines was 70-fold higher than that produced by stimulated macrophage cell lines. CONCLUSIONS; Both intestinal epithelial and smooth muscle cells demonstrate the ability to release significant amounts of IL-6. The profound response to IL-1beta and TNF-alpha stimulation by both cell lines suggests that human intestinal parenchymal cells, influenced by paracrine mediators liberated from proinflammatory cells, might significantly contribute to the overall systemic inflammatory response by producing IL-6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745542      PMCID: PMC1781593          DOI: 10.1080/0962935031000096917

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  49 in total

1.  Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease.

Authors:  M C Holub; E Makó; T Dévay; M Dank; C Szalai; A Fenyvesi; A Falus
Journal:  Scand J Gastroenterol Suppl       Date:  1998

Review 2.  The role of cytokines in the failing human heart.

Authors:  S Kapadia; Z Dibbs; K Kurrelmeyer; D Kalra; Y Seta; F Wang; B Bozkurt; H Oral; N Sivasubramanian; D L Mann
Journal:  Cardiol Clin       Date:  1998-11       Impact factor: 2.213

Review 3.  The role of IL-6 type cytokines and their receptors in bone.

Authors:  S C Manolagas
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

4.  Increase of interleukin-6 in the intestinal mucosa and muscularis following chronic rejection after small bowel transplantation.

Authors:  K J Walgenbach; P F Heeckt; J C Kalff; J Stanson; T L Whiteside; A Hirner; A J Bauer
Journal:  Transplant Proc       Date:  1998-09       Impact factor: 1.066

Review 5.  Antagonism of the IL-6 cytokine subfamily--a potential strategy for more effective therapy in rheumatoid arthritis.

Authors:  G Carroll; M Bell; H Wang; H Chapman; J Mills
Journal:  Inflamm Res       Date:  1998-01       Impact factor: 4.575

Review 6.  Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.

Authors:  S K Fried; D A Bunkin; A S Greenberg
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

Review 7.  Human herpesvirus 8--the first human Rhadinovirus.

Authors:  F Neipel; J C Albrecht; B Fleckenstein
Journal:  J Natl Cancer Inst Monogr       Date:  1998

8.  Neurotransmitters modulate cytokine-stimulated interleukin 6 secretion in rat intestinal smooth muscle cells.

Authors:  G Van Assche; G Barbara; Y Deng; P Lovato; J Gauldie; S M Collins
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

9.  Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease.

Authors:  F Arai; T Takahashi; K Furukawa; K Matsushima; H Asakura
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

10.  Characterization of allograft rejection in an experimental model of small intestinal transplantation.

Authors:  M Hayashi; O M Martinez; S M Krams; W Burns; C O Esquivel
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.267

View more
  23 in total

1.  Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.

Authors:  Jennifer Steele; Kevin Chen; Xingmin Sun; Yongrong Zhang; Haiying Wang; Saul Tzipori; Hanping Feng
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

Review 2.  New concepts in the generation and functions of IgA.

Authors:  Oliver Pabst
Journal:  Nat Rev Immunol       Date:  2012-10-29       Impact factor: 53.106

Review 3.  IgA Responses to Microbiota.

Authors:  Jeffrey J Bunker; Albert Bendelac
Journal:  Immunity       Date:  2018-08-21       Impact factor: 31.745

4.  Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds.

Authors:  Fatou Ndiaye; Tri Vuong; Jairo Duarte; Rotimi E Aluko; Chantal Matar
Journal:  Eur J Nutr       Date:  2011-03-27       Impact factor: 5.614

5.  Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

Authors:  Tuxiong Huang; Gregorio Perez-Cordon; Lianfa Shi; Guangchao Li; Xingmin Sun; Xiaoning Wang; Jufang Wang; Hanping Feng
Journal:  Pathog Dis       Date:  2015-01-27       Impact factor: 3.166

6.  Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors.

Authors:  Gabriel Vinderola; Chantal Matar; Gabriela Perdigon
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 7.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 8.  The human intestinal B-cell response.

Authors:  J Spencer; L M Sollid
Journal:  Mucosal Immunol       Date:  2016-07-27       Impact factor: 7.313

9.  Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.

Authors:  Simon A Hirota; Vadim Iablokov; Sarah E Tulk; L Patrick Schenck; Helen Becker; Jimmie Nguyen; Samir Al Bashir; Tanis C Dingle; Austin Laing; Jianrui Liu; Yan Li; Jeff Bolstad; George L Mulvey; Glen D Armstrong; Wallace K MacNaughton; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

10.  Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages.

Authors:  Xingmin Sun; Xiangyun He; Saul Tzipori; Ralf Gerhard; Hanping Feng
Journal:  Microb Pathog       Date:  2009-03-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.